Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Executive VP and CFO of H.B. Fuller, John J. Corkrean, files Form 4 detailing changes in beneficial ownership, including acquisition and disposal of performance stock units and holdings of employee stock options and restricted stock units.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 with the SEC.
- The filing reports changes in beneficial ownership of H.B. Fuller's securities.
- Corkrean acquired 3,509 performance stock units on January 22, 2025, which convert into common stock on a 1-for-1 basis and represent H.B. Fuller achieving return on invested capital payout at 110% of the target level.
- Corkrean disposed of 3,509 performance stock units on January 24, 2025.
- The filing also details Corkrean's holdings of employee stock options, phantom units, and restricted stock units with varying vesting schedules and exercise prices.
- As of the report, Corkrean directly owns 47,187 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions and holdings.
Positives
- The acquisition of performance stock units indicates a potential positive outlook for H.B. Fuller's return on invested capital, as the units were awarded based on the company achieving 110% of the target level.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their alignment with shareholder interests.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the executive's holdings and transactions.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of grant for employee stock option with an exercise price of $43.48. |
| 01/26/2018 | Date of grant for employee stock option with an exercise price of $50.1. |
| 01/25/2019 | Date of grant for employee stock option with an exercise price of $53.57. |
| 01/24/2020 | Date of grant for employee stock option with an exercise price of $45.05. |
| 01/24/2021 | Date of grant for employee stock option with an exercise price of $48.35. |
| 01/27/2022 | Date of grant for employee stock option with an exercise price of $51.89. |
| 01/24/2023 | Date of grant for employee stock option with an exercise price of $72.94 and restricted stock units that vest in three annual installments beginning on this date. |
| 01/24/2024 | Date of grant for employee stock option with an exercise price of $68.17 and restricted stock units that vest in three annual installments beginning on this date. |
| 01/22/2025 | Transaction date for acquisition of 3,509 performance stock units. |
| 01/23/2025 | Date of signature for the Form 4 filing. |
| 01/24/2025 | Vesting date of performance stock units and transaction date for disposal of 3,509 performance stock units. |
| 01/26/2025 | Date of grant for employee stock option with an exercise price of $77.72 and restricted stock units that vest in three annual installments beginning on this date. |
| 05/17/2026 | Expiration date for employee stock option with an exercise price of $43.48. |
| 01/26/2027 | Expiration date for employee stock option with an exercise price of $50.1. |
| 01/25/2028 | Expiration date for employee stock option with an exercise price of $53.57. |
| 01/24/2029 | Expiration date for employee stock option with an exercise price of $45.05. |
| 01/24/2030 | Expiration date for employee stock option with an exercise price of $48.35. |
| 01/27/2031 | Expiration date for employee stock option with an exercise price of $51.89. |
| 01/24/2032 | Expiration date for employee stock option with an exercise price of $72.94. |
| 01/24/2033 | Expiration date for employee stock option with an exercise price of $68.17. |
| 01/26/2034 | Expiration date for employee stock option with an exercise price of $77.72. |
Keywords
Form 4, beneficial ownership, H.B. Fuller, stock options, restricted stock units, performance stock units, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.